Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q1 FY2027 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
14.21%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Grace Therapeutics, Inc.
Market Cap
$33.61M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$33.63M
Gross Margin
49.68%
TTM Avg
60.09%
3Y Avg
64.56%
5Y Avg
72.92%
Market Cap
$33.29M
Gross Margin
57.46%
TTM Avg
78.73%
3Y Avg
89.36%
5Y Avg
76.24%
Market Cap
$32.93M
Gross Margin
83.79%
TTM Avg
85.97%
3Y Avg
84.60%
5Y Avg
84.69%
Market Cap
$34.97M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$35.52M
Gross Margin
39.56%
TTM Avg
49.73%
3Y Avg
-33.76%
5Y Avg
-21.28%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $33.61M | 0.00% | 0.00% | 0.00% | 0.00% |
| Scilex Holding Company (SCLX)vs › | $33.63M | 49.68% | 60.09% | 64.56% | 72.92% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.29M | 57.46% | 78.73% | 89.36% | 76.24% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.93M | 83.79% | 85.97% | 84.60% | 84.69% |
| Elutia Inc (ELUT)vs › | $34.35M | 57.82% | 48.80% | 47.77% | 46.56% |
| Nephros, Inc. (NEPH)vs › | $32.79M | 60.31% | 61.36% | 57.30% | 56.95% |
| HeartBeam, Inc. (BEAT)vs › | $32.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | 0.00% | 0.00% | 0.00% | 0.00% |
| QT Imaging Holdings, Inc. (QTI)vs › | $35.52M | 39.56% | 49.73% | -33.76% | -21.28% |
| Nortech Systems Incorporated (NSYS)vs › | $31.52M | 16.44% | 14.13% | 15.03% | 13.67% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 65.22% |
| 2020-12-31 | 55.56% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2016-11-30 | 0.00% |
| 2016-08-31 | 0.00% |
| 2016-05-31 | 0.00% |
| 2016-02-29 | -266.09% |
| 2015-11-30 | 52.87% |
| 2015-08-31 | 66.64% |
| 2015-05-31 | 48.47% |
| 2015-02-28 | -3.96% |
| 2014-11-30 | 19.46% |
| 2014-08-31 | 40.16% |
| 2014-05-31 | 53.58% |
| 2014-02-28 | 38.35% |
| 2013-11-30 | 43.12% |
| 2013-08-31 | 43.15% |
| 2013-05-31 | 70.23% |
| 2013-02-28 | 8.27% |
| 2012-11-30 | 43.23% |
| 2012-08-31 | 47.86% |
| 2012-05-31 | 66.61% |
| 2012-02-29 | 65.52% |
| 2011-11-30 | 0.00% |
| 2011-08-31 | 0.00% |
| 2011-05-31 | 100.00% |
| 2011-02-28 | 100.00% |
| 2010-11-30 | 0.00% |
| 2010-08-31 | 0.00% |
| 2010-05-31 | 0.00% |
| 2010-02-28 | 0.00% |
| 2009-11-30 | 0.00% |
| 2009-08-31 | 0.00% |
| 2009-05-31 | 0.00% |
| 2008-11-30 | 0.00% |
